Wednesday, 24 April 2024

Northeast Science and Technology Center campus rolls out next phase development of former Merck HQ in US

14 February 2024 | News

Onyx Equities and Machine Investment Group join forces with Outshine Properties for campus renovations

Onyx Equities, managing member of the joint venture that owns The Northeast Science and Technology (NEST) Center, has announced the next phase of the campus' evolution into an international life science and biotechnology hub. After purchasing the property from Merck in 2023 and Merck vacating all but one building on the campus on January 1st of this year, Onyx Equities is teaming up with Outshine Properties to implement a strategy for renovating and leasing the NEST campus. The strategic partnership is poised to catapult the NEST Center campus to the epicenter of the biotech world.

The 100+ acre campus already boasts 2 million square feet of existing facilities, including 1.4 million square feet of state-of-the-art laboratories and biomanufacturing facilities, 500,000 square feet of Class-A professional office space, an existing vivarium, and over 30 acres of redevelopment opportunities.

Prospective life science tenants, especially those in cutting-edge research such as cell, gene, and immunotherapy, will find an environment able to meet their specialized requirements. The campus also offers robust utility infrastructure capable of supporting advanced data storage and processing capabilities, allowing organizations the opportunity of leveraging technology such as artificial intelligence for their research and development.

On-campus renovations will kick off with the 280,000-square-foot pilot research and development plant, branded as 11 NEST, which is specifically tailored to meet the unique needs of life science companies, especially those engaged in biomanufacturing.

In the coming year, the campus will host its first-ever life science conference in partnership with Bisnow. The conference will bring together life science real estate professionals for transformative discussions and unparalleled insights, setting the stage for exploration of innovation within the life sciences industry.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account